Addressing Cross-Border Transit Demand at the New Huanggang Port: Weixin Pay, Wonder and Koon Wing Motors Join Forces to Introduce ‘Wonder Transit X’ Smart Mobility Platform, Driving Digital Transformation of Green Minibuses and Fostering Public Transit Integration Between HK and the Chinese Mainland 
Hengrui Pharma Reports 2026 Interim Results as Innovation and Globalization Continue to Drive Business Momentum 
Onchain Foundation Becomes Strategic Shareholder of Trust Square Ecosystem AG to Accelerate Global Innovation Platform 
Champion REIT Announces 2026 Interim Results 
Guoquan (2517.HK) 2026 Interim Results: Dual Growth in Scale and Efficiency, Powered by the Dual Drivers of Membership Stickiness and Product Matrix Datametrex Secures Rights to Distribute Portable COVID Lamp PCR Test
Toronto, Ontario–(Newsfile Corp. – December 13, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB:…
Ni Hsin Group Launches BB2GO EV Bikes for F&B Business
KUALA LUMPUR, Dec 13, 2021 – (ACN Newswire) – Ni Hsin Group Berhad’s (formerly known…
Fujitsu Launches Global Strategic Partner Academy Program to Tackle Global IT Skills and Experience Shortage
TOKYO, Dec 13, 2021 – (JCN Newswire) – Fujitsu today announces an ambitious Global Strategic…
Dotz Nano Signs Distribution Agreements in Malaysia and Thailand for Its COVID-19 Diagnostic Test Kits
Melbourne, Australia–(Newsfile Corp. – December 12, 2021) – Dotz Nano Limited (ASX: DTZ) (“Dotz” or…
All-New Outlander PHEV Model Wins Technology Car of the Year in 2021-2022 Car of the Year Japan Awards
TOKYO, Dec 13, 2021 – (JCN Newswire) – Mitsubishi Motors Corporation today announced that the…
Confluent and Alibaba Cloud Announce Partnership to set Data in Motion in Mainland China
SINGAPORE–(BUSINESS WIRE)–Confluent, Inc. (NASDAQ: CFLT), the platform for data in motion, and Alibaba Cloud, the…
RewirEd Summit – Driving Innovative, Radical Change in Global Education
Youth, skills & future of work focus on Day One B-Roll highlights available via: https://we.tl/t-6jJuSMLA2G…
EverGrow Coin Hyper Deflationary Token Is Setting New Standard in Defi
NEWARK, DE / ACCESSWIRE / December 12, 2021 / EverGrow Coin The Hyper Deflationary Token,…
Newly Launched Cryptocurrency EverGrow Coin Distributes $30M Passes 110K Token Holders and $30M in Rewards
NEWARK, DE / ACCESSWIRE / December 12, 2021 / Being the first cryptocurrency that rewards…
MorphoSys Presents Latest Data from the Phase 2 MANIFEST Study Evaluating the Potential of Pelabresib in the Treatment of Myelofibrosis
MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib…
NFT Market Welcomes A New Rival: Socialogue – The Social NFT Marketplace
Vilnius, Lithuania–(Newsfile Corp. – December 12, 2021) – The NFT community celebrates the launch of…
New Concept Property Management has You Covered In Multiple Locations
TUCSON, AZ / ACCESSWIRE / December 12, 2021 / One of the biggest concerns landlords…
Blender Bites Announces Historic Record Revenues Over the Last Three Months: Representing a 2,266% Increase Compared to Same Period in 2020
VANCOUVER, BC / ACCESSWIRE / December 11, 2021 / Blender Bites Ltd. (the “Company“, “Blender…
Tessa Therapeutics Showcases Positive Clinical Data from Phase 1 Study of “Off the Shelf” CD30 Cell Therapy at 2021 Annual Meeting of American Society of Hematology (ASH)
Oral poster presentation highlights data from dose-escalation trial of allogeneic CD30.CAR EBVST cell therapy (TT11X)…
Neoleukin Therapeutics Announces Preclinical Data Highlighting Activity of NL-201 in Hematologic Malignancies at 63rd American Society of Hematology Annual Meeting (ASH 2021)
– Poster presentation highlights NL-201 activity in multiple myeloma stem cell transplant model – – Abstract…
Novartis Scemblix® demonstrates sustained response rate in 48-week follow-up in patients with chronic myeloid leukemia
Updated 48-week data from Phase III ASCEMBL trial consistent with improved major molecular response (MMR)…
Vincerx Pharma Presents Data on PTEFb/CDK9 Inhibitor VIP152 in DLBCL and CLL at the 63rd American Society of Hematology Annual Meeting
VIP152 has increased selectivity and potency compared to other CDK9 inhibitors in development, consistent across…
IGM Biosciences Presents Clinical Data from IGM-2323 in Patients with Advanced B Cell Malignancies at 2021 American Society of Hematology Annual Meeting
– Data Presented Shows Novel Bispecific IgM Antibody is Active in Heavily Pre-treated Patients with…
Novartis Kymriah® demonstrates strong responses in high-risk patients with relapsed or refractory follicular lymphoma in extended study follow-up
Complete and overall response rates and durability of response were well maintained across majority of…
Cellectis Reports Encouraging Clinical Data from BALLI-01 Study in Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, and Preclinical Data from TALGlobin01 at the 63rd American Society of Hematology Annual Meeting
Cellectis’ Proprietary Product Candidate UCART22 was Administered after Lymphodepletion with Fludarabine, Cyclophosphamide and Alemtuzumab (FCA)…